title: Iron removal with phlebotomy and recombinant human erythropoietin in secondary hemochromatosis after allogeneic bone marrow transplantation.
authors.affiliation: Department of Pediatrics, Ewha Womans University College of Medicine, Yangchon-gu, Seoul, Korea.
authors.forename: Su Jin
authors.initials: SJ
authors.lastname: Cho
authors.forename: Soo Jeong
authors.initials: SJ
authors.lastname: Lee
authors.forename: Eun Sun
authors.initials: ES
authors.lastname: Yoo
authors.forename: Kyung-Ha
authors.initials: KH
authors.lastname: Ryu
authors.forename: Ju Young
authors.initials: JY
authors.lastname: Seoh
authors.forename: Ki Sook
authors.initials: KS
authors.lastname: Hong
authors.forename: Heasoo
authors.initials: H
authors.lastname: Koo
mesh_terms: D001219:Aspartate Aminotransferases / Q000097:blood; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005293:Ferritins / Q000097:blood; D006086:Graft vs Host Disease; D006432:Hemochromatosis / Q000097:blood / Q000628:therapy*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000601:surgery; D008111:Liver Function Tests; D009190:Myelodysplastic Syndromes / Q000601:surgery; D018962:Phlebotomy; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D005293:Ferritins; D001219:Aspartate Aminotransferases